These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19254846)

  • 1. Discovery of novel Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase inhibitors.
    Freitas RF; Prokopczyk IM; Zottis A; Oliva G; Andricopulo AD; Trevisan MT; Vilegas W; Silva MG; Montanari CA
    Bioorg Med Chem; 2009 Mar; 17(6):2476-82. PubMed ID: 19254846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anacardic acid derivatives as inhibitors of glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi.
    Pereira JM; Severino RP; Vieira PC; Fernandes JB; da Silva MF; Zottis A; Andricopulo AD; Oliva G; Corrêa AG
    Bioorg Med Chem; 2008 Oct; 16(19):8889-95. PubMed ID: 18789702
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of Trypanosoma cruzi GAPDH by "bi-substrate" analogues.
    Ladame S; Fauré R; Denier C; Lakhdar-Ghazal F; Willson M
    Org Biomol Chem; 2005 Jun; 3(11):2070-2. PubMed ID: 15917890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for selective inhibition of trypanosomatid glyceraldehyde-3-phosphate dehydrogenase: molecular docking and 3D QSAR studies.
    Guido RV; Oliva G; Montanari CA; Andricopulo AD
    J Chem Inf Model; 2008 Apr; 48(4):918-29. PubMed ID: 18303835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of organic solvents on the enzyme activity of Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase in calorimetric assays.
    Wiggers HJ; Cheleski J; Zottis A; Oliva G; Andricopulo AD; Montanari CA
    Anal Biochem; 2007 Nov; 370(1):107-14. PubMed ID: 17693383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective tight binding inhibitors of trypanosomal glyceraldehyde-3-phosphate dehydrogenase via structure-based drug design.
    Aronov AM; Verlinde CL; Hol WG; Gelb MH
    J Med Chem; 1998 Nov; 41(24):4790-9. PubMed ID: 9822549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The development of an immobilized enzyme reactor containing glyceraldehyde-3-phosphate dehydrogenase from Trypanosoma cruzi: the effect of species' specific differences on the immobilization.
    Cardoso CL; de Moraes MC; Guido RV; Oliva G; Andricopulo AD; Wainer IW; Cass QB
    Analyst; 2008 Jan; 133(1):93-9. PubMed ID: 18087619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New 3-piperonylcoumarins as inhibitors of glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH) from Trypanosoma cruzi.
    de Marchi AA; Castilho MS; Nascimento PG; Archanjo FC; del Ponte G; Oliva G; Pupo MT
    Bioorg Med Chem; 2004 Sep; 12(18):4823-33. PubMed ID: 15336261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural analysis of human liver glyceraldehyde-3-phosphate dehydrogenase.
    Ismail SA; Park HW
    Acta Crystallogr D Biol Crystallogr; 2005 Nov; 61(Pt 11):1508-13. PubMed ID: 16239728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational changes in Leishmania mexicana glyceraldehyde-3-phosphate dehydrogenase induced by designed inhibitors.
    Suresh S; Bressi JC; Kennedy KJ; Verlinde CL; Gelb MH; Hol WG
    J Mol Biol; 2001 Jun; 309(2):423-35. PubMed ID: 11371162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the two phosphate binding sites of an analogue of the thioacyl intermediate for the Trypanosoma cruzi glyceraldehyde-3-phosphate dehydrogenase-catalyzed reaction, from its crystal structure.
    Castilho MS; Pavão F; Oliva G; Ladame S; Willson M; Périé J
    Biochemistry; 2003 Jun; 42(23):7143-51. PubMed ID: 12795610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and characterization of an immobilized enzyme reactor (IMER) based on human glyceraldehyde-3-phosphate dehydrogenase for on-line enzymatic studies.
    Cardoso CL; Lima VV; Zottis A; Oliva G; Andricopulo AD; Wainer IW; Moaddel R; Cass QB
    J Chromatogr A; 2006 Jul; 1120(1-2):151-7. PubMed ID: 16297925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacophore-based virtual screening approach for the discovery of Trypanosoma cruzi GAPDH inhibitors.
    Maluf FV; Andricopulo AD; Oliva G; Guido RV
    Future Med Chem; 2013 Nov; 5(17):2019-35. PubMed ID: 24215344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase: structure, catalytic mechanism and targeted inhibitor design.
    Souza DH; Garratt RC; Araújo AP; Guimarães BG; Jesus WD; Michels PA; Hannaert V; Oliva G
    FEBS Lett; 1998 Mar; 424(3):131-5. PubMed ID: 9580189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the development of dual-targeted glyceraldehyde-3-phosphate dehydrogenase/trypanothione reductase inhibitors against Trypanosoma brucei and Trypanosoma cruzi.
    Belluti F; Uliassi E; Veronesi G; Bergamini C; Kaiser M; Brun R; Viola A; Fato R; Michels PA; Krauth-Siegel RL; Cavalli A; Bolognesi ML
    ChemMedChem; 2014 Feb; 9(2):371-82. PubMed ID: 24403089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integration of methods in cheminformatics and biocalorimetry for the design of trypanosomatid enzyme inhibitors.
    Prokopczyk IM; Ribeiro JF; Sartori GR; Sesti-Costa R; Silva JS; Freitas RF; Leitão A; Montanari CA
    Future Med Chem; 2014 Jan; 6(1):17-33. PubMed ID: 24358945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
    Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
    Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The catalytic mechanism of glyceraldehyde 3-phosphate dehydrogenase from Trypanosoma cruzi elucidated via the QM/MM approach.
    Reis M; Alves CN; Lameira J; Tuñón I; Martí S; Moliner V
    Phys Chem Chem Phys; 2013 Mar; 15(11):3772-85. PubMed ID: 23389436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent inhibitor scaffold against Trypanosoma cruzi trans-sialidase.
    Arioka S; Sakagami M; Uematsu R; Yamaguchi H; Togame H; Takemoto H; Hinou H; Nishimura S
    Bioorg Med Chem; 2010 Feb; 18(4):1633-40. PubMed ID: 20097567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the farnesyl pyrophosphate synthase of Trypanosoma cruzi by homology modeling and molecular dynamics.
    Sigman L; Sánchez VM; Turjanski AG
    J Mol Graph Model; 2006 Nov; 25(3):345-52. PubMed ID: 16540358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.